14-day RSI
48.61
+5.80+13.55%
27 November 2024
Summary:
Adaptimmune Therapeutics stock 14-day relative strength index is 48.61, with the most recent change of +5.80 (+13.55%) on 27 November 2024. According to this value, ADAP stock is neither oversold nor overboughtADAP RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP RSI Performance
PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
---|---|---|---|---|
todaytoday | +13.6% | +1.4% | -0.8% | -0.2% |
1 m1 month | +103.5% | -6.1% | -19.3% | -2.1% |
3 m3 months | -13.3% | -42.0% | -27.5% | +5.8% |
6 m6 months | +15.3% | -31.3% | -33.4% | +20.2% |
ytdytd | -34.8% | -10.5% | +52.9% | +25.9% |
1 y1 year | +28.2% | +57.0% | +31.8% | +11.7% |
5 y5 years | -6.7% | -25.9% | -24.3% | -61.8% |
ADAP RSI High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 48.76 | -0.3% | 20.67 | +135.2% |
3 m | 3 months | 57.60 | -15.6% | 20.67 | +135.2% |
6 m | 6 months | 69.79 | -30.4% | 20.67 | +135.2% |
1 y | 1 year | 82.60 | -41.1% | 20.67 | +135.2% |
3 y | 3 years | 87.97 | -44.7% | 16.54 | +193.9% |
5 y | 5 years | 93.00 | -47.7% | 16.54 | +193.9% |
alltime | all time | 95.77 | -49.2% | 15.84 | +206.9% |
Adaptimmune Therapeutics Stock RSI History
Date | Value |
---|---|
2024 | 48.61(-34.8%) |
2023 | 74.60(+69.6%) |
2022 | 43.98(+1.6%) |
2021 | 43.29(-28.2%) |
2020 | 60.31(+21.3%) |
Date | Value |
---|---|
2019 | 49.73(-10.3%) |
2018 | 55.41(+80.1%) |
2017 | 30.76(-29.1%) |
2016 | 43.40(-35.0%) |
2015 | 66.78 |
FAQ
- What is Adaptimmune Therapeutics 14-day relative strength index?
- What is the all time high 14-day RSI for Adaptimmune Therapeutics?
What is Adaptimmune Therapeutics 14-day relative strength index?
The current 14-day RSI of ADAP is 48.61
What is the all time high 14-day RSI for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high 14-day relative strength index is 95.77